Drug Pricing Reforms Keep Pressure on Biotech, Healthcare ETFs
September 26, 2019 at 17:47 PM EDT
Healthcare and biotechnology-related ETFs are taking a blow as drug-pricing reforms weigh on the sector outlook. The Health Care Select Sector SPDR ETF (NYSEArca: XLV) fell another 0.6% and the iShares Nasdaq Biotechnology ETF (IBB) declined 2.0% in back-to-back selling on Thursday. The biotech...